摘要
目的：探讨艾司西酞普兰合并团体心理治疗对女性抑郁症住院患者的临床疗效和改善社会功能的效果。方法：选择符合CCMD一3抑郁症诊断标准的女性抑郁症患者，随机分成研究组和对照组各31例，研究组进行团体心理治疗联合艾司西酞普兰抗抑郁药物治疗，对照组仅给予药物治疗。比较2组社会功能缺陷筛选量表（SDSS）、汉密尔顿抑郁量表（HAMD）评分及临床总体疗效。结果：2组治疗后HAMD量表评分与治疗前有显著性差异（P〈0．01），治疗后研究组与对照组HAMD得分存在显著性差异（P〈0．01）；2组治疗后较治疗前相比SDSS量表分存在显著性差异（P〈0．01），治疗后研究组SDSS量表分显著低于对照组，有显著性差异（P〈0．01）；研究组痊愈14例，显进11例，好转4例，无效2例，总有效率93．5％。对照组痊愈12例，显进11例，好转3例，无效5例，总有效率83．9％。研究组与对照组临床总体疗效有显著性差异（P〈0．05）。结论：团体心理治疗合并艾司西酞普兰对于女性抑郁症住院患者的疗效优于单纯艾司西酞普兰药物治疗，值得临床推广应用。
Objective： To investigate the clinical efficacy of escitalopram consolidated group psychotherapy for women with depression in hospitalized patients and improve the effectiveness of social functions. Methods： Women with depression patients met CCMD -3 diagnostic criteria for depression were randomized into the study group and the control group of 31 cases, the research team conducted a joint group psychotherapy antidepressant escitalopram treatment, the control group received only drug treatment. Comparison of the two groups Social Disability Screening Scale （SDSS）, Hamilton Depression Rating Scale （HAMD） score and overall clinical efficacy. Results： the HAMD scale score of two groups after treatment and before treatment there was a significant difference （ P 〈 0. 01 ）. After the treatment, the study group and the control groupthere were significant differences in HAMD score （ P 〈 0. 01 ） ; the two group after treatment than before treatment compared with the SDSS scale has significant difference （P 〈0. O1 ）, after treatment of the study group the SDSS score was significantly lower than that of the control group, there was significant difference （ P 〈 0. 01 ） ; the study group 14 cases were cured, 11 cases significantly into, improved in 4 cases, invalid in 2 cases, the total efficiency of 93.5%. The control group cured 12 cases, marked improvement in 11 cases, 3 cases were improved, 5 cases ineffective, the total efficiency of 83.9%. The study group had significant difference with the control group, the total clinical efficacy （ x^2 = 28.39, p 〈 0.05 ）. Conclusion： Conclusion： Efficacy of Group Psychotherapy merger escitalopram for women with depression in hospitalized patients is better than escitalopram medication, worthy of clinical application.
出处
《中国伤残医学》
2016年第8期30-31,共2页
Chinese Journal of Trauma and Disability Medicine
